research and development
New head of R&D at Biogen
April 27, 2016Research and Development Biogen, Pfizer, R&D, erhlers, michael, michael erhlers, research and development
Biogen (NASDAQ: BIIB) has announced the appointment of Dr Michael Ehlers as executive vice president, research and development. His role …
Allergan to partner with Heptares in Alzheimer’s disease collaboration
April 7, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments
Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …
What would BREXIT mean for pharma?
February 16, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development
It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
The case for leaders with scientific acumen in pharma
January 25, 2016Medical Communications, Research and Development research and development
Pharmaceutical companies are currently undergoing fundamental, disruptive changes to conventional research and development models. This is in an attempt to …
Analysts say pharma R&D returns challenged by drag of high costs
December 16, 2015Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts
The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
Pharma deals crucial to cutting R&D costs
December 16, 2015Research and Development GlobalData, R&D, drug development, pharma, research and development
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
Pharma companies warned on patent box changes
December 16, 2015Research and Development R&D, patent box, pharma, research and development, tax
Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …
Which are pharma’s most innovative companies?
December 11, 2015Medical Communications, Research and Development GSK, Roche, research and development
It has been a record-breaking year for the pharmaceutical industry in terms of deals, but what about the underlying innovation …
Pharma leaders urge UK Government not to cut spending
September 9, 2015Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding
Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
Pharma industry worth more than $1 trillion – and growing
August 5, 2015Sales and Marketing pharma sales, research and development
Global pharmaceutical sales are set to continue rising beyond the $1 trillion milestone reached in 2014, according to newly-released figures. …
Report: ‘R&D isn’t paying’
December 3, 2013Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters
On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …
AstraZeneca shores up Cambridge move
July 11, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development
AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …
R&D costs rise ten-fold
December 4, 2012Research and Development, Sales and Marketing OHE, R&D, research and development
Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …
The brain drain
April 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development
Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …
German biotech Apceth appoints Prof. Ralf Huss
October 19, 2011Research and Development appointment, research and development
Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Latest content
Five Facts about cardiovascular disease
